{
  "actions": [
    {
      "acted_at": "2014-09-18", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2862-113", 
  "bill_type": "s", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Paul, Rand", 
      "sponsored_at": "2014-11-13", 
      "state": "KY", 
      "thomas_id": "02082", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Whitehouse, Sheldon", 
      "sponsored_at": "2014-09-18", 
      "state": "RI", 
      "thomas_id": "01823", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2014-09-18", 
  "number": "2862", 
  "official_title": "A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4299-113", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr4709-113", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014", 
  "sponsor": {
    "district": null, 
    "name": "Hatch, Orrin G.", 
    "state": "UT", 
    "thomas_id": "01351", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2014-09-18", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Administrative remedies", 
    "Congressional oversight", 
    "Crime and law enforcement", 
    "Department of Justice", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug trafficking and controlled substances", 
    "Government studies and investigations", 
    "Health care coverage and access", 
    "Licensing and registrations", 
    "Prescription drugs", 
    "Retail and wholesale trades"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2015-09-01T10:22:26-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d113:SN2862:@@@L&summ2=m&"
}